StockData
Myomo, Inc. logo

Myomo, Inc. (MYO) stock

MYONYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/3030% below fair value
$0.88−0.04 (-4.23%)

Close on Nov 18, 2026Market cap $34.85MP/E –Yield –

Myomo r&d expenses

Research and development expenses are spending on new products and technology.

Myomo's R&D Expenses for the twelve months ending Jun 30, 2026 was $6.50M, down 1.6% year over year. For fiscal 2025 it was $6.94M, up 45.5% from the year before. The highest annual figure on record is $6.94M in fiscal 2025.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$6.94M+45.5%
FY2024Dec 31, 2024$4.77M+81.0%
FY2023Dec 31, 2023$2.64M+6.2%
FY2022Dec 31, 2022$2.48M-2.9%
FY2021Dec 31, 2021$2.56M+53.2%
FY2020Dec 31, 2020$1.67M-4.6%
FY2019Dec 31, 2019$1.75M-4.8%
FY2018Dec 31, 2018$1.84M+5.0%
FY2017Dec 31, 2017$1.75M+56.3%
FY2016Dec 31, 2016$1.12M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.72M-14.0%
Q1 FY2026Mar 31, 2026$1.62M-9.3%
Q4 FY2025Dec 31, 2025$1.62M+4.2%
Q3 FY2025Sep 30, 2025$1.53M+22.3%
Q2 FY2025Jun 30, 2025$2.00M+98.7%
Q1 FY2025Mar 31, 2025$1.79M+87.2%
Q4 FY2024Dec 31, 2024$1.56M+77.6%
Q3 FY2024Sep 30, 2024$1.25M+74.1%
Q2 FY2024Jun 30, 2024$1.01M+78.5%
Q1 FY2024Mar 31, 2024$956.22K+100.5%
Q4 FY2023Dec 31, 2023$878.01K+75.7%
Q3 FY2023Sep 30, 2023$717.26K+3.9%
Q2 FY2023Jun 30, 2023$564.24K-10.8%
Q1 FY2023Mar 31, 2023$476.99K-27.7%
Q4 FY2022Dec 31, 2022$499.67K-36.6%
Q3 FY2022Sep 30, 2022$690.41K+7.7%
Q2 FY2022Jun 30, 2022$632.87K+5.5%
Q1 FY2022Mar 31, 2022$659.54K+25.4%
Q4 FY2021Dec 31, 2021$787.63K+88.1%
Q3 FY2021Sep 30, 2021$641.23K+85.5%
Q2 FY2021Jun 30, 2021$600.12K+50.9%
Q1 FY2021Mar 31, 2021$525.97K+3.8%
Q4 FY2020Dec 31, 2020$418.76K-5.4%
Q3 FY2020Sep 30, 2020$345.67K-20.2%
Q2 FY2020Jun 30, 2020$397.81K-7.0%
Q1 FY2020Mar 31, 2020$506.95K+13.6%
Q4 FY2019Dec 31, 2019$442.52K-16.4%
Q3 FY2019Sep 30, 2019$433.07K-3.7%
Q2 FY2019Jun 30, 2019$427.57K-12.2%
Q1 FY2019Mar 31, 2019$446.35K+19.9%
Q4 FY2018Dec 31, 2018$529.62K+48.4%
Q3 FY2018Sep 30, 2018$449.67K+36.5%
Q2 FY2018Jun 30, 2018$486.98K-31.3%
Q1 FY2018Mar 31, 2018$372.36K+4.3%
Q4 FY2017Dec 31, 2017$356.87K-12.2%
Q3 FY2017Sep 30, 2017$329.36K+38.6%
Q2 FY2017Jun 30, 2017$708.62K–
Q1 FY2017Mar 31, 2017$356.89K–
Q4 FY2016Dec 31, 2016$406.62K–
Q3 FY2016Sep 30, 2016$237.69K–

More Myomo figures

See a number that looks wrong?